| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/02/2001 | WO2001005950A3 Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
| 08/02/2001 | WO2001005808A3 In vitro selection and optional identification of polypeptides using solid support carriers |
| 08/02/2001 | WO2001004352A3 Dna polymorphisms in sterol regulator element binding proteins |
| 08/02/2001 | WO2001004305A3 Human proteins involved in detoxification |
| 08/02/2001 | WO2001000828A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/02/2001 | WO2001000804A3 Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins |
| 08/02/2001 | WO2001000234A3 Methods and compositions for engineering of attenuated vaccines |
| 08/02/2001 | WO2000071756A3 Mathematical analysis for the estimation of changes in the level of gene expression |
| 08/02/2001 | WO2000070095A3 Homogeneous isothermal amplification and detection of nucleic acids using a template switch oligonucleotide |
| 08/02/2001 | WO2000070036A3 Genes expressed in hippocampus |
| 08/02/2001 | WO2000066777A3 Assay based on the analysis of dna melting curves |
| 08/02/2001 | WO2000066770A3 Method for producing a chemically and thermally stable solid phase matrix for polymerase chain reaction (pcr) and dna hybridisation assay |
| 08/02/2001 | WO2000061808A3 Methods for detecting nucleic acids indicative of cancer |
| 08/02/2001 | WO2000056932A3 Germline-competent avian cells |
| 08/02/2001 | WO2000050580A3 Composition, methods and reagents for the synthesis of a soluble form of human phex |
| 08/02/2001 | WO2000046391A9 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
| 08/02/2001 | WO2000040246A9 Detection of human immunodeficiency virus |
| 08/02/2001 | WO2000036151A9 A heterogeneous assay for pyrophosphate detection |
| 08/02/2001 | WO2000026666A9 Multiple marker characterization of single cells |
| 08/02/2001 | WO2000026241A9 Novel compositions and methods of screening for t-cell and b-cell activation modulators |
| 08/02/2001 | WO2000023602A3 Regulated expression using conditional er retention domains |
| 08/02/2001 | WO1999049025A3 Human vault rna |
| 08/02/2001 | US20010011154 Automatic electrophysiological measuring apparatus / method |
| 08/02/2001 | US20010011139 Polynucleotides labeled with dibenzorhodamine dyes |
| 08/02/2001 | US20010011130 Materials and methods for detection of oxalate |
| 08/02/2001 | US20010011129 Immobilized analytical element |
| 08/02/2001 | US20010011124 Genetic engineering |
| 08/02/2001 | US20010011077 Secreted cysteine rich protein-6 (SCRP-6); polynucleotides and processes for producing polypeptides |
| 08/02/2001 | US20010010929 Polynucleotides and polypeptides belonging to the uncoupling proteins family |
| 08/02/2001 | US20010010928 Protozoan expression system |
| 08/02/2001 | US20010010926 New immunoregulatory protein lst-1 |
| 08/02/2001 | US20010010925 Medical diagnosis/screening, inflammation; extracellular signal molecules; antitumor and antimetastasis agents |
| 08/02/2001 | US20010010921 Cell-free and cell-based assays for screening drugs to treat eating disorders; dietetics; obesity, cachexia |
| 08/02/2001 | US20010010917 Method and device for preparing samples for detecting a nucleotide sequence |
| 08/02/2001 | US20010010915 Stable complex of nucleic acids |
| 08/02/2001 | US20010010914 Nucleic acid marker for cancer |
| 08/02/2001 | US20010010913 Isolated polypeptide |
| 08/02/2001 | US20010010912 nrdF |
| 08/02/2001 | US20010010910 Hybrid nucleic acids |
| 08/02/2001 | US20010010908 Reagents and methods useful for detecting diseases of the prostate |
| 08/02/2001 | US20010010907 Crosslinking transcription factor to nucleic acids |
| 08/02/2001 | US20010010906 Method and kit for diagnosing and/or quantifying by sandwich hybridisation of nucleic acid sequences on solid support |
| 08/02/2001 | US20010010905 Amplification; measurement |
| 08/02/2001 | US20010010904 Genetic engineering; overlapping Dna sequences |
| 08/02/2001 | US20010010903 Method for comparison of dna base sequences |
| 08/02/2001 | US20010010902 Sequence-specific detection of nucleic acids |
| 08/02/2001 | US20010010901 Genetic engineering |
| 08/02/2001 | US20010010826 Contacting the site of wound with a matrix comprising gelatin and a nitric oxide scavanger to increase blood cirulation; nitric oxide scavanger are selected from L-arganine analog, dextran, heparin, cysteine and cystine |
| 08/02/2001 | EP1144607A3 Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
| 08/02/2001 | DE10011926A1 Genetisch veränderte Fibroblastenzellen Genetically modified fibroblast cells |
| 08/02/2001 | DE10003580A1 Verfahren, Kit und DNA-Sonden zum Nachweis einer Pilz-Spezies in klinischem Material Method, kit and DNA probes for the detection of fungal species in clinical material |
| 08/02/2001 | DE10002803A1 System zur internen qualitativen und quantitativen Validierung von Markerindices System of internal qualitative and quantitative validation of marker indices |
| 08/02/2001 | DE10002566A1 Verfahren und Einrichtung zur Bestimmung des Schmelzpunktes und/oder der Bindungskonstante von Substanzen, wie z. B. DNA-Sequenzen, in einer Probe Method and device for determining the melting point and / or the binding constant of substances, such as. For example, DNA sequences in a sample |
| 08/02/2001 | DE10002402A1 Verfahren zum Bestimmen von Nukleinsäure-Modifikationen A method for determining nucleic acid modifications |
| 08/02/2001 | CA2399109A1 T cell receptor libraries |
| 08/02/2001 | CA2398812A1 Novel stabilized formulations for chemiluminescent assays |
| 08/02/2001 | CA2398790A1 Methods of identifying synthetic transcriptional and translational regulatory elements, and compositions relating to same |
| 08/02/2001 | CA2398784A1 Method, kit and dna probes for detecting a fungal species in clinical material |
| 08/02/2001 | CA2398743A1 Novel mhc class ii restricted t cell epitopes from the cancer antigen, ny eso-1 |
| 08/02/2001 | CA2398660A1 Human cyr61 |
| 08/02/2001 | CA2398633A1 Identifying genes associated with a qtl corn digestibility locus |
| 08/02/2001 | CA2398564A1 Nuclear hormone receptors |
| 08/02/2001 | CA2398548A1 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 08/02/2001 | CA2398546A1 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 08/02/2001 | CA2398541A1 Synthetic internal ribosome entry sites and methods of identifying same |
| 08/02/2001 | CA2398430A1 Human protein kinases and protein kinase-like enzymes |
| 08/02/2001 | CA2398411A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2398396A1 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides |
| 08/02/2001 | CA2398382A1 Method, system and computer software for providing a genomic web portal |
| 08/02/2001 | CA2398271A1 Compositions and methods for performing biological reactions |
| 08/02/2001 | CA2398227A1 17 human secreted proteins |
| 08/02/2001 | CA2398107A1 Methods for analysis of gene expression |
| 08/02/2001 | CA2398104A1 Polymorphisms in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications |
| 08/02/2001 | CA2398084A1 Three-dimensional matrix body, and device and method for measuring contractions of a cell tissue |
| 08/02/2001 | CA2398003A1 Phosphodiesterases |
| 08/02/2001 | CA2397839A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2397416A1 A system for developing assays for personalized medicine |
| 08/02/2001 | CA2397407A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395885A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395872A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395858A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395857A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395832A1 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 08/02/2001 | CA2395827A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395816A1 Nucleic acids, proteins and antibodies |
| 08/02/2001 | CA2395815A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395787A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395734A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395693A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395676A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395671A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395666A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395654A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395403A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395398A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395295A1 Nucleic acids, proteins and antibodies |
| 08/02/2001 | CA2395178A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2394841A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2394411A1 Method of processing a sample containing at least one biological element |
| 08/02/2001 | CA2394332A1 Chimeric neuropeptide y receptors |